EHR Vendor Opens Data to Providers, Researchers
Practice Fusion, a vendor of free, advertiser-sponsored electronic health records software for ambulatory practices, has introduced a data analytics product enabling access to a de-identified subset of data from more than 81 million patient records.
Practice Fusion, a vendor of free, advertiser-sponsored electronic health records software for ambulatory practices, has introduced a data analytics product enabling access to a de-identified subset of data from more than 81 million patient records.
Called Insight, the database is available to physicians, researchers, analysts and all other stakeholders, including consumers. Physician users do not have to be customers of the vendor. Among other features, the database includes more than 2,000 different medications.
Some data access is free and deeper dives into data are available for a fee. The free version enables analysis of current and historical market share of prescription medications compared with other medications in the same drug class and trending diagnoses data enabling a real-time view of current outbreaks and to track diagnoses over time to identify new trends in seasonal infections, as well as the ability to view the top 100 diagnoses seen nationally on the Practice Fusion platform and to determine the proportion of patients with a diagnosis by body mass index, age group or sex.
More granular analytics functions in a premium version of the database are available for a fee. They include:
* Patient Profile: A view of patients on a given medication by age, sex, body mass index and chronic condition.
* Prescriber Profile: The types of physicians writing a given medication by specialty and the reasons for prescribing.
* Rx Switching: How physicians use specific medications and if they switch patients from one drug to another in the course of treatment.
* Treatment Flow: A longitudinal look at how a patient cycles through multiple therapies over time and ends up with a specific treatment.
* Customized reports of real-time and in-depth performance analysis of any drug therapy in the outpatient market that the vendor conducts upon request.
The company is not releasing specific details on pricing for the premium services, saying fees will vary depending on client needs. Pharmaceutical, finance and research professionals are showing the earliest interest in the premium plan, says Chris Hogg, associate vice president of data science at Practice Fusion.
The free analytics platform is available here. Brief registration is required. For information on the premium version of the platform, send an email to insight@practicefusion.com.
Called Insight, the database is available to physicians, researchers, analysts and all other stakeholders, including consumers. Physician users do not have to be customers of the vendor. Among other features, the database includes more than 2,000 different medications.
Some data access is free and deeper dives into data are available for a fee. The free version enables analysis of current and historical market share of prescription medications compared with other medications in the same drug class and trending diagnoses data enabling a real-time view of current outbreaks and to track diagnoses over time to identify new trends in seasonal infections, as well as the ability to view the top 100 diagnoses seen nationally on the Practice Fusion platform and to determine the proportion of patients with a diagnosis by body mass index, age group or sex.
More granular analytics functions in a premium version of the database are available for a fee. They include:
* Patient Profile: A view of patients on a given medication by age, sex, body mass index and chronic condition.
* Prescriber Profile: The types of physicians writing a given medication by specialty and the reasons for prescribing.
* Rx Switching: How physicians use specific medications and if they switch patients from one drug to another in the course of treatment.
* Treatment Flow: A longitudinal look at how a patient cycles through multiple therapies over time and ends up with a specific treatment.
* Customized reports of real-time and in-depth performance analysis of any drug therapy in the outpatient market that the vendor conducts upon request.
The company is not releasing specific details on pricing for the premium services, saying fees will vary depending on client needs. Pharmaceutical, finance and research professionals are showing the earliest interest in the premium plan, says Chris Hogg, associate vice president of data science at Practice Fusion.
The free analytics platform is available here. Brief registration is required. For information on the premium version of the platform, send an email to insight@practicefusion.com.